News & Events
14 September 2022
PREFERABLE at the European Society for Medical Oncology (ESMO) Congress
Results and experiences from PREFERABLE were shared at the ESMO Congress in Paris, 9-13 September 2022
13 September 2022
8th Consortium Meeting in Paris
On the 8th & 9th of September we met in Paris for the 8th PREFERABLE Consortium Meeting.
8 August 2022
EFFECT inclusion of 350 patients reached!
We have reached our target of 350 patient inclusions in the PREFERABLE EFFECT study!

PREFERABLE consists of an international consortium of nine academic partners, one cutting edge game development and software engineering SME , one science-driven clinical trial management company and one European patient organisation (EUROPA DONNA – The European Breast Cancer Coalition, representing 47 countries throughout Europe). The partners are from seven countries in the Netherlands, Germany, Sweden, Poland, Spain, Italy and Australia and are coordinated by the University Medical Center Utrecht, the Netherlands.